Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population
I. Aksentijevich et al., Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population, AM J HU GEN, 64(4), 1999, pp. 949-962
Citations number
30
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Molecular Biology & Genetics
Familial Mediterranean fever (FMF) is a recessive disorder characterized by
episodes of fever with serositis or synovitis. The FMF gene (MEFV) was clo
ned recently, and four missense mutations were identified. Here we present
data from non-Ashkenazi Jewish and Arab patients in whom we had not origina
lly found mutations and from a new, more ethnically diverse panel. Among 90
symptomatic mutation-positive individuals, 11 mutations accounted for 79%
of carrier chromosomes. Of the two mutations that are novel, one alters the
same residue (680) as a previously known mutation, and the other (P369S) i
s located in exon 3. Consistent with another recent report, the E148Q mutat
ion was observed in patients of several ethnicities and on multiple microsa
tellite haplotypes, but haplotype data indicate an ancestral relationships
between non-Jewish Italian and Ashkenazi Jewish patients with FMF and other
affected populations. Among similar to 200 anonymous Ashkenazi Jewish DNA
samples, the MEFV carrier frequency was 21%, with E148Q the most common mut
ation. Several lines of evidence indicate reduced penetrance among Ashkenaz
i Jews, especially for E148Q, P369S, and K695R. Nevertheless, E148Q helps a
ccount for recessive inheritance in an Ashkenazi family previously reported
as an unusual case of dominantly inherited FMF The presence of three frequ
ent MEFV mutations in multiple Mediterranean populations strongly suggests
a heterozygote advantage in this geographic region.